REGENERON PHARMACEUTICALS (REGN) Stock Cash Flow
NASDAQ:REGN - Nasdaq - US75886F1075 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 4.50B | 4.41B | 3.95B | 4.34B | 8.08B | |||
| Depreciation Amortization | 495.70M | 482.90M | 421.00M | 341.40M | 286.20M | |||
| Income Taxes - Deferred | -706.00M | -757.30M | -837.80M | -746.40M | -147.10M | |||
| Change In Working Capital | -929.20M | -618.30M | -94.10M | -243.30M | -1.92B | |||
| Interest Paid | N/A | 52.60M | 73.10M | 53.70M | 55.80M | |||
| Taxes Paid | N/A | 743.00M | 870.30M | 1.50B | 1.22B | |||
| Other non cash items | 593.30M | 900.60M | 1.15B | 1.32B | 783.40M | |||
| OPERATING CASH FLOW | 3.95B | 4.42B | 4.59B | 5.01B | 7.08B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -991.30M | -881.60M | -926.40M | -1.62B | -551.90M | |||
| Other Investing Activity | 857.80M | -1.59B | -2.26B | -2.17B | -4.83B | |||
| INVESTING CASH FLOW | -133.50M | -2.47B | -3.19B | -3.78B | -5.38B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | -2.51B | -1.14B | -1.09B | -563.30M | 26.90M | |||
| Other Financing Activity | -733.40M | -1.06B | -700.60M | -445.70M | -1.03B | |||
| FINANCING CASH FLOW | -3.34B | -2.20B | -1.79B | -1.01B | -1.01B | |||
| Exchange Rate Effect | 400.00K | -700.00K | -400.00K | N/A | N/A | |||
| CHANGE IN CASH | 483.20M | -248.80M | -381.60M | 221.30M | 690.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 3.95B | 4.42B | 4.59B | 5.01B | 7.08B | |||
| Capital Expenditure | -991.30M | -881.60M | -926.40M | -1.62B | -551.90M | |||
| FREE CASH FLOW | 2.96B | 3.54B | 3.67B | 3.40B | 6.53B | |||
All data in USD